Quest Diagnostics News

Baird Adjusts Quest Diagnostics' Price Target to $144 From $138

MT NewswiresApr 30 08:37 ET

Piper Sandler Reaffirms Their Hold Rating on Quest Diagnostics (DGX)

TipRanksApr 30 07:06 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Apellis Pharmaceuticals (APLS), Quest Diagnostics (DGX) and Healthcare Services (HCSG)

TipRanksApr 26 03:08 ET

Quest Diagnostics: A Hold Rating Amid Solid Earnings and Strategic Caution

TipRanksApr 26 02:15 ET

Quest Diagnostics Analyst Ratings

BenzingaApr 25 14:35 ET

Barclays Maintains Equal-Weight on Quest Diagnostics, Raises Price Target to $144

BenzingaApr 25 14:36 ET

UBS Adjusts Price Target on Quest Diagnostics to $146 From $139, Maintains Neutral Rating

MT NewswiresApr 24 09:48 ET

Quest Diagnostics Analyst Ratings

BenzingaApr 24 07:52 ET

Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), Tactile Systems Technology (TCMD) and Danaher (DHR)

TipRanksApr 24 07:20 ET

Evercore ISI Raises Quest Diagnostics Price Target to $145 From $140

MT NewswiresApr 23 14:16 ET

Quest Diagnostics: Strong Q1 Outperformance Spurs Buy Rating and Raised Full-Year Guidance

TipRanksApr 23 09:37 ET

Barclays Remains a Hold on Quest Diagnostics (DGX)

TipRanksApr 16 05:57 ET

Quest Diagnostics Analyst Ratings

BenzingaMar 20 11:50 ET

Truist Financial Sticks to Their Hold Rating for Quest Diagnostics (DGX)

TipRanksMar 20 07:15 ET

Leerink Partners Initiates Coverage On Quest Diagnostics With Market Perform Rating, Announces Price Target of $135

BenzingaFeb 26 09:17 ET

Quest Diagnostics Analyst Ratings

BenzingaFeb 26 09:15 ET

Piper Sandler Remains a Hold on Quest Diagnostics (DGX)

TipRanksFeb 8 07:38 ET

Jefferies Upgrades Quest to Buy, Sees 2024 Guidance as Conservative

Seeking AlphaFeb 7 13:00 ET

Jefferies Upgrades Quest Diagnostics to Buy From Hold, Adjusts Price Target to $155 From $140

MT NewswiresFeb 7 12:50 ET

Jefferies Upgrades Quest Diagnostics to Buy, Raises Price Target to $155

BenzingaFeb 7 06:23 ET